Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms

doi:10.5493/wjem.v16.i1.116584

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

(42)

(34)

(0)

(710)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Exp Med. Mar 20, 2026; 16(1): 116584
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.116584

Table 2 Classification of the severity of allergic rhinitis symptoms: Severity of the symptoms

Severity	Types
Severity	Sneezing¹	Rhinorrhea²	Nasal blockage
4 (++++)	≥ 21 times	≥ 21 times	Nose completely obstructed all day
3 (+++)	11-20 times	11-20 times	Severe nasal blockage causing oral breathing during a day
2 (++)	6-10 times	60-10 times	Severe nasal blockage causing occasional oral breathing during a day
1 (+)	1-5 times	1-5 times	Nasal blockage without oral breathing
0 (-)	Below +	Below +	Below +

¹Average number of episodes of paroxysmal sneezing in a day.

²Average number of episodes of nose blowing per day.

Full Size Table

Citation: Katagiri F, Hatoyama-Tanaka S, Watanabe T, Takayanagi R, Suzuki M, Yamada Y. Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms. World J Exp Med 2026; 16(1): 116584
URL: https://www.wjgnet.com/2220-315x/full/v16/i1/116584.htm
DOI: https://dx.doi.org/10.5493/wjem.v16.i1.116584

Katagiri F, Hatoyama-Tanaka S, Watanabe T, Takayanagi R, Suzuki M, Yamada Y. Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms. World J Exp Med 2026; 16(1): 116584 [PMID: 41883453 DOI: 10.5493/wjem.v16.i1.116584]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.